Global Nuclear Receptor ROR Gamma Market By Product Type (BBI-6000, GRC-39815Action) And By End-Users/Application (Chronic Obstructive Pulmonary Disease, Asthma) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-984475
  • April 2021
  • Pharmaceuticals
  • 135 Pages

Report Preview

The Nuclear Receptor ROR Gamma market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Nuclear Receptor ROR Gamma market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the Nuclear Receptor ROR Gamma market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Nuclear Receptor ROR Gamma market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Nuclear Receptor ROR Gamma market along with their effects over the forecast period. Similarly, according to the region Nuclear Receptor ROR Gamma market research report includes the study of opportunities available in the market situation.

The Nuclear Receptor ROR Gamma market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type BBI-6000, GRC-39815Action, R&D Progress, GSK-2981278, IMU-366, INV-17, Others
Applications Chronic Obstructive Pulmonary Disease, Asthma, Axial Spondyloarthritis, Breast Cancer, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, Beijing Hanmi Pharmaceutical, Biogen Inc, AbbVie Inc, Eurofins Advinus, Brickell Biotech Inc, Pfizer Inc, Phenex Pharmaceuticals AG, Reata Pharmaceuticals Inc, Bristol-Myers Squibb Company, Celgene Corp, Eli Lilly, Glenmark Pharmaceuticals, Lead Pharma Holding BV

Global Nuclear Receptor ROR Gamma Market Segmentation by Regions:
In regional analysis, Nuclear Receptor ROR Gamma market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Nuclear Receptor ROR Gamma market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Nuclear Receptor ROR Gamma Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for Nuclear Receptor ROR Gamma Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for Nuclear Receptor ROR Gamma Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for Nuclear Receptor ROR Gamma Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for Nuclear Receptor ROR Gamma Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global Nuclear Receptor ROR Gamma Market Segmentation by Type:
On the basis of product type, global Nuclear Receptor ROR Gamma market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: BBI-6000, GRC-39815Action, R&D Progress, GSK-2981278, IMU-366, INV-17, Others

Global Nuclear Receptor ROR Gamma Market Segmentation by Applications:
On the basis of the end users/applications, Nuclear Receptor ROR Gamma research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Chronic Obstructive Pulmonary Disease, Asthma, Axial Spondyloarthritis, Breast Cancer, Others

Major Key Players for Global Nuclear Receptor ROR Gamma Market:
The Nuclear Receptor ROR Gamma market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, Beijing Hanmi Pharmaceutical, Biogen Inc, AbbVie Inc, Eurofins Advinus, Brickell Biotech Inc, Pfizer Inc, Phenex Pharmaceuticals AG, Reata Pharmaceuticals Inc, Bristol-Myers Squibb Company, Celgene Corp, Eli Lilly, Glenmark Pharmaceuticals, Lead Pharma Holding BV

Important Points Covered by Report:
  • To analyze the value of the Nuclear Receptor ROR Gamma market, according to the key region.
  • To study the Nuclear Receptor ROR Gamma market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Nuclear Receptor ROR Gamma market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Nuclear Receptor ROR Gamma research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Nuclear Receptor ROR Gamma market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Nuclear Receptor ROR Gamma market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Nuclear Receptor ROR Gamma market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Nuclear Receptor ROR Gamma market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Nuclear Receptor ROR Gamma market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Genfit SA
  • GlaxoSmithKline Plc
  • Aurigene Discovery Technologies
  • Beijing Hanmi Pharmaceutical
  • Biogen Inc
  • AbbVie Inc
  • Eurofins Advinus
  • Brickell Biotech Inc
  • Pfizer Inc
  • Phenex Pharmaceuticals AG
  • Reata Pharmaceuticals Inc
  • Bristol-Myers Squibb Company
  • Celgene Corp
  • Eli Lilly
  • Glenmark Pharmaceuticals
  • Lead Pharma Holding BV
  • BBI-6000
  • GRC-39815Action
  • R&D Progress
  • GSK-2981278
  • IMU-366
  • INV-17
  • Others
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Axial Spondyloarthritis
  • Breast Cancer
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Nuclear Receptor ROR Gamma Market Snapshot
          2.1.1. Global Nuclear Receptor ROR Gamma Market By Type,2019
               2.1.1.1.BBI-6000
               2.1.1.2.GRC-39815Action
               2.1.1.3.R&D Progress
               2.1.1.4.GSK-2981278
               2.1.1.5.IMU-366
               2.1.1.6.INV-17
               2.1.1.7.Others
          2.1.2. Global Nuclear Receptor ROR Gamma Market By Application,2019
               2.1.2.1.Chronic Obstructive Pulmonary Disease
               2.1.2.2.Asthma
               2.1.2.3.Axial Spondyloarthritis
               2.1.2.4.Breast Cancer
               2.1.2.5.Others
          2.1.3. Global Nuclear Receptor ROR Gamma Market By End-use,2019
          2.1.4. Global Nuclear Receptor ROR Gamma Market By Geography,2019

3. Global Nuclear Receptor ROR Gamma Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Nuclear Receptor ROR Gamma Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Nuclear Receptor ROR Gamma Market Size (US$), By Type, 2018 – 2028

5. Global Nuclear Receptor ROR Gamma Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Nuclear Receptor ROR Gamma Market Size (US$), By Application, 2018 – 2028

6. Global Nuclear Receptor ROR Gamma Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Nuclear Receptor ROR Gamma Market Size (US$), By End-use, 2018 – 2028

7. Global Nuclear Receptor ROR Gamma Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Nuclear Receptor ROR Gamma Market Analysis, 2018 – 2028 
          7.2.1. North America Nuclear Receptor ROR Gamma Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Nuclear Receptor ROR Gamma Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Nuclear Receptor ROR Gamma Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Nuclear Receptor ROR Gamma Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Nuclear Receptor ROR Gamma Market Analysis, 2018 – 2028 
          7.3.1.  Europe Nuclear Receptor ROR Gamma Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Nuclear Receptor ROR Gamma Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Nuclear Receptor ROR Gamma Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Nuclear Receptor ROR Gamma Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Nuclear Receptor ROR Gamma Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Nuclear Receptor ROR Gamma Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Nuclear Receptor ROR Gamma Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Nuclear Receptor ROR Gamma Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Nuclear Receptor ROR Gamma Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Nuclear Receptor ROR Gamma Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Nuclear Receptor ROR Gamma Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Nuclear Receptor ROR Gamma Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Nuclear Receptor ROR Gamma Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Nuclear Receptor ROR Gamma Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Nuclear Receptor ROR Gamma Market Analysis, 2018 – 2028 
          7.6.1.  MEA Nuclear Receptor ROR Gamma Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Nuclear Receptor ROR Gamma Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Nuclear Receptor ROR Gamma Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Nuclear Receptor ROR Gamma Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Nuclear Receptor ROR Gamma Providers
        8.4.1 Genfit SA
                8.1.1 Business Description
                8.1.2 Genfit SA Geographic Operations
                8.1.3 Genfit SA Financial Information
                8.1.4 Genfit SA Product Positions/Portfolio
                8.1.5 Genfit SA Key Developments
        8.4.2 GlaxoSmithKline Plc
                8.2.1 Business Description
                8.2.2 GlaxoSmithKline Plc Geographic Operations
                8.2.3 GlaxoSmithKline Plc Financial Information
                8.2.4 GlaxoSmithKline Plc Product Positions/Portfolio
                8.2.5 GlaxoSmithKline Plc Key Developments
        8.4.3 Aurigene Discovery Technologies
                8.3.1 Business Description
                8.3.2 Aurigene Discovery Technologies Geographic Operations
                8.3.3 Aurigene Discovery Technologies Financial Information
                8.3.4 Aurigene Discovery Technologies Product Positions/Portfolio
                8.3.5 Aurigene Discovery Technologies Key Developments
        8.4.4 Beijing Hanmi Pharmaceutical
                8.4.1 Business Description
                8.4.2 Beijing Hanmi Pharmaceutical Geographic Operations
                8.4.3 Beijing Hanmi Pharmaceutical Financial Information
                8.4.4 Beijing Hanmi Pharmaceutical Product Positions/Portfolio
                8.4.5 Beijing Hanmi Pharmaceutical Key Developments
        8.4.5 Biogen Inc
                8.5.1 Business Description
                8.5.2 Biogen Inc Geographic Operations
                8.5.3 Biogen Inc Financial Information
                8.5.4 Biogen Inc Product Positions/Portfolio
                8.5.5 Biogen Inc Key Developments
        8.4.6 AbbVie Inc
                8.6.1 Business Description
                8.6.2 AbbVie Inc Geographic Operations
                8.6.3 AbbVie Inc Financial Information
                8.6.4 AbbVie Inc Product Positions/Portfolio
                8.6.5 AbbVie Inc Key Developments
        8.4.7 Eurofins Advinus
                8.7.1 Business Description
                8.7.2 Eurofins Advinus Geographic Operations
                8.7.3 Eurofins Advinus Financial Information
                8.7.4 Eurofins Advinus Product Positions/Portfolio
                8.7.5 Eurofins Advinus Key Developments
        8.4.8 Brickell Biotech Inc
                8.8.1 Business Description
                8.8.2 Brickell Biotech Inc Geographic Operations
                8.8.3 Brickell Biotech Inc Financial Information
                8.8.4 Brickell Biotech Inc Product Positions/Portfolio
                8.8.5 Brickell Biotech Inc Key Developments
        8.4.9 Pfizer Inc
                8.9.1 Business Description
                8.9.2 Pfizer Inc Geographic Operations
                8.9.3 Pfizer Inc Financial Information
                8.9.4 Pfizer Inc Product Positions/Portfolio
                8.9.5 Pfizer Inc Key Developments
        8.4.10 Phenex Pharmaceuticals AG
                8.10.1 Business Description
                8.10.2 Phenex Pharmaceuticals AG Geographic Operations
                8.10.3 Phenex Pharmaceuticals AG Financial Information
                8.10.4 Phenex Pharmaceuticals AG Product Positions/Portfolio
                8.10.5 Phenex Pharmaceuticals AG Key Developments
        8.4.11 Reata Pharmaceuticals Inc
                8.11.1 Business Description
                8.11.2 Reata Pharmaceuticals Inc Geographic Operations
                8.11.3 Reata Pharmaceuticals Inc Financial Information
                8.11.4 Reata Pharmaceuticals Inc Product Positions/Portfolio
                8.11.5 Reata Pharmaceuticals Inc Key Developments
        8.4.12 Bristol-Myers Squibb Company
                8.12.1 Business Description
                8.12.2 Bristol-Myers Squibb Company Geographic Operations
                8.12.3 Bristol-Myers Squibb Company Financial Information
                8.12.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.12.5 Bristol-Myers Squibb Company Key Developments
        8.4.13 Celgene Corp
                8.13.1 Business Description
                8.13.2 Celgene Corp Geographic Operations
                8.13.3 Celgene Corp Financial Information
                8.13.4 Celgene Corp Product Positions/Portfolio
                8.13.5 Celgene Corp Key Developments
        8.4.14 Eli Lilly
                8.14.1 Business Description
                8.14.2 Eli Lilly Geographic Operations
                8.14.3 Eli Lilly Financial Information
                8.14.4 Eli Lilly Product Positions/Portfolio
                8.14.5 Eli Lilly Key Developments
        8.4.15 Glenmark Pharmaceuticals
                8.15.1 Business Description
                8.15.2 Glenmark Pharmaceuticals Geographic Operations
                8.15.3 Glenmark Pharmaceuticals Financial Information
                8.15.4 Glenmark Pharmaceuticals Product Positions/Portfolio
                8.15.5 Glenmark Pharmaceuticals Key Developments
        8.4.16 Lead Pharma Holding BV
                8.16.1 Business Description
                8.16.2 Lead Pharma Holding BV Geographic Operations
                8.16.3 Lead Pharma Holding BV Financial Information
                8.16.4 Lead Pharma Holding BV Product Positions/Portfolio
                8.16.5 Lead Pharma Holding BV Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Nuclear Receptor ROR Gamma Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Nuclear Receptor ROR Gamma Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Nuclear Receptor ROR Gamma Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Nuclear Receptor ROR Gamma Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Nuclear Receptor ROR Gamma Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Nuclear Receptor ROR Gamma Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Nuclear Receptor ROR Gamma Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Nuclear Receptor ROR Gamma Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Nuclear Receptor ROR Gamma Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Nuclear Receptor ROR Gamma Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Nuclear Receptor ROR Gamma Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Nuclear Receptor ROR Gamma Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Nuclear Receptor ROR Gamma Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Nuclear Receptor ROR Gamma Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Nuclear Receptor ROR Gamma Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Nuclear Receptor ROR Gamma Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Nuclear Receptor ROR Gamma: Market Segmentation 
FIG. 2 Global Nuclear Receptor ROR Gamma Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Nuclear Receptor ROR Gamma Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Nuclear Receptor ROR Gamma Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Nuclear Receptor ROR Gamma Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Nuclear Receptor ROR Gamma Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Nuclear Receptor ROR Gamma Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Nuclear Receptor ROR Gamma Providers, 2019
FIG. 11 Global Nuclear Receptor ROR Gamma Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Nuclear Receptor ROR Gamma Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Nuclear Receptor ROR Gamma Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Nuclear Receptor ROR Gamma Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Nuclear Receptor ROR Gamma Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Nuclear Receptor ROR Gamma Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Nuclear Receptor ROR Gamma Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Nuclear Receptor ROR Gamma Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Nuclear Receptor ROR Gamma market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Nuclear Receptor ROR Gamma Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Nuclear Receptor ROR Gamma Market Value, By Segment1, 2018 – 2028
TABLE  North America Nuclear Receptor ROR Gamma Market Value, By Segment2, 2018 – 2028
TABLE  North America Nuclear Receptor ROR Gamma Market Value, By Country, 2018 – 2028
TABLE  Europe Nuclear Receptor ROR Gamma Market Value, By Segment1, 2018 – 2028
TABLE  Europe Nuclear Receptor ROR Gamma Market Value, By Segment2, 2018 – 2028
TABLE  Europe Nuclear Receptor ROR Gamma Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Nuclear Receptor ROR Gamma Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Nuclear Receptor ROR Gamma Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Nuclear Receptor ROR Gamma Market Value, By Country, 2018 – 2028
TABLE  Latin America Nuclear Receptor ROR Gamma Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Nuclear Receptor ROR Gamma Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Nuclear Receptor ROR Gamma Market Value, By Country, 2018 – 2028
TABLE  MEA Nuclear Receptor ROR Gamma Market Value, By Segment1, 2018 – 2028
TABLE  MEA Nuclear Receptor ROR Gamma Market Value, By Segment2, 2018 – 2028
TABLE  MEA Nuclear Receptor ROR Gamma Market Value, By Country, 2018 – 2028
TABLE  Genfit SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aurigene Discovery Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Beijing Hanmi Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biogen Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eurofins Advinus: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Brickell Biotech Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Phenex Pharmaceuticals AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Reata Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Celgene Corp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Glenmark Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lead Pharma Holding BV: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Nuclear Receptor ROR Gamma Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Nuclear Receptor ROR Gamma Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Nuclear Receptor ROR Gamma Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Nuclear Receptor ROR Gamma Market, By Geography, 2019 (US$ Mn)
FIG.  Global Nuclear Receptor ROR Gamma Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Nuclear Receptor ROR Gamma Providers, 2016
FIG.  Global Nuclear Receptor ROR Gamma Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global BBI-6000 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global GRC-39815Action Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global R&D Progress Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global GSK-2981278 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global IMU-366 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global INV-17 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Nuclear Receptor ROR Gamma Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Chronic Obstructive Pulmonary Disease Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Asthma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Axial Spondyloarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Breast Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Nuclear Receptor ROR Gamma Market Value, 2018 – 2028, (US$ Mn)